SecBot SecBot

CV

CapsoVision, Inc
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001378325 Healthcare & Medical Devices
$7.01 +0.02 (+0.29%)
Oct 26 4:00 PM ET · prev $6.99
Market cap
$361.7M
Small cap
Median target
$9.50
+36% · range $9.00–10.00
Next earnings
Nov 12
in 17 days · EPS est. −$0.14
1 year
+44.2%
from $4.86 · Oct 27
30 days
+1.3%
from $6.92
52-week range
$4.59–14.42
−51% from high · low Nov 4
Avg volume 20D
124.6K
Oct 23 spike 320.2K
Short interest
2.10M
≈4.0% of shares · +10.8%
Days to cover
5.4
at average volume
Insider net
+$16.0M
2 buyers · 1 seller · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
12
analyzed by SecBot
SecBot read MIXED 7 reports · 90 days
Balance 3 bearish · 2 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 6/7 ·Next Earnings date, Nov 12, 2026
Strongest BULLISH CapsoVision announced FDA clearance of AI Highlights, its AI-assisted reading tool for the CapsoCam Plus…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $16.0M at an average $5.73. 1 insider sold $8.6K. Price is 22% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 24 added (0 new), 2 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.120 → −$0.145 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest +10.8% to 2.10M shares. 5.4 days to cover, ≈4.0% of shares.

  • TrendUPTREND

    10% above its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.ADD1,896,088$14.4M
GEODE CAPITAL MANAGEMENT, LLCADD578,482$4.4M
STATE STREET CORPADD410,241$3.1M
VANGUARD PORTFOLIO MANAGEMENT LLCADD240,425$1.8M
NORTHERN TRUST CORPADD220,095$1.7M
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD79,360$601.5K
Bank of New York Mellon CorpADD75,021$568.7K
Nuveen, LLCADD46,011$348.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2026
12-month targets · 2 analysts

Price is below the lowest target. Median implies +36%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Mar 27, 2026Benchmark
MAINTAIN
MAINTAINSpeculative Buy
Dec 31, 2025Benchmark
MAINTAIN
MAINTAINSpeculative Buy
Jul 28, 2025Benchmark
INITIATE
INITIATESpeculative Buy

Insider ledger

Form 4
$16.0M
bought · 2 insiders
$8.6K
sold · 1 insider
+22.3%
vs their $5.73 cost
DateInsiderTypeValue
Sep 18, 2026
HARARI ELIYAHOU ET AL
10%+ Owner
BUY$5.0M
Sep 18, 2026
HARARI ELIYAHOU ET AL
10%+ Owner
BUY$5.0M
Sep 15, 2026
Shen Ching Hang
10%+ Owner
BUY$5.0M
Jul 17, 2026
HARARI ELIYAHOU ET AL
10%+ Owner
BUY$411.0K
Jul 8, 2026
HARARI ELIYAHOU ET AL
10%+ Owner
BUY$495.1K
Jul 1, 2026
Shields David Stanley
Director
AWARD1,710 sh
Jun 30, 2026
GOUW JULIA S
Director
EXERCISE$15.3K
Jun 30, 2026
Harari Michele
Director
EXERCISE$15.3K

Earnings setup

Estimates
Nov 12
reports in 17 days
−$0.14
EPS estimate, this quarter
−21%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.14-$0.15–-$0.14+0.0%$3.8M
Next Q-$0.12-$0.12–-$0.11+0.0%$4.6M
Current FY-$0.56-$0.56–-$0.56+0.0%$14.9M
Next FY-$0.44-$0.45–-$0.43+0.0%$19.8M

Short side

FINRA· Sep 30, 2026
2,104,385
shares short
+10.8%
vs prior settlement
5.4
days to cover
≈4.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 Other
CapsoVision to Present at the 20th Annual LD Micro Main Event
CapsoVision to Present at the 20th Annual LD Micro Main Event...
Sep 28, 2026 SEC
CapsoVision announced FDA clearance of AI Highlights, its AI-assisted reading tool for the CapsoCam Plus capsule…
8-K — Impact 6/10
Sep 28, 2026 Press
CapsoVision received FDA clearance for AI Highlights, an AI-assisted reading tool for its CapsoCam Plus capsule…
Impact 5/10
Sep 23, 2026 SEC
Two 10% owners, Eliyahou Harari and Ching-Hang Shen (via Star One Global Capital), each purchased 878,700 shares at…
CLUSTER — Impact 4/10
Sep 22, 2026 SEC
In Q2 2026, 24 institutional investors accumulated CapsoVision shares with a net $2.8M inflow, while only 2 trimmed…
INST-CLUSTER — Impact 3/10
Sep 18, 2026 Insider
HARARI ELIYAHOU ET AL bought 878,735 shares
10%+ Owner @ $5.69 ($5.0M)
Sep 18, 2026 Insider
HARARI ELIYAHOU ET AL bought 878,734 shares
10%+ Owner @ $5.69 ($5.0M)
Sep 15, 2026 Insider
Shen Ching Hang bought 878,734 shares
10%+ Owner @ $5.69 ($5.0M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 12, 2026
Earnings date
CV Q3 2026 Earnings Scheduled — 2026-11-12
Recent
Oct 13, 2026
Press release
CapsoVision to Present at the 20th Annual LD Micro Main Event
CapsoVision to Present at the 20th Annual LD Micro Main Event...
Sep 28, 2026
FDA
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
AI-assisted reading tool designed to aid physician review of small bowel capsule endoscopy studies performed due to suspected bleeding using the…
Sep 3, 2026
Press release
CapsoVision to Participate in Upcoming Investor Conferences
CapsoVision to Participate in Upcoming Investor Conferences
Aug 13, 2026
Earnings date
CV Q2 2026 Earnings Scheduled — 2026-08-13
Aug 3, 2026
Press release
CapsoVision® Announces International Launch of AI Highlights
AI-assisted review feature designed to support physician review of small bowel capsule endoscopy studies using the CapsoCam Plus® system AI-assisted…

SecBot reports

12 filings · 4 press releases · 4 bullish · 3 bearish · 5 neutral
All CV filing & press-release reports (16)